Post-Transplant Cyclophosphamide and Tacrolimus–Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, Valentina Coha, Lorenzo D'Ambrosio, Elena Vassallo, Marco Fizzotti, Francesca Nesi, Luisa Gioeni, Massimo Berger, Alessandra Polo, Loretta Gammaitoni, Paolo Becco, Lidia Giraudo, Monica Mangioni, Dario Sangiolo, Giovanni Grignani, Delia Rota–Scalabrini, Antonino Sottile, Franca Fagioli, Massimo Aglietta Biology of Blood and Marrow Transplantation Volume 23, Issue 3, Pages 459-466 (March 2017) DOI: 10.1016/j.bbmt.2016.12.636 Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Transplant-related complications. (A) Cumulative incidence of aGVHD. (B) Cumulative incidence of cGVHD. (C) Cumulative incidence of NRM. Biology of Blood and Marrow Transplantation 2017 23, 459-466DOI: (10.1016/j.bbmt.2016.12.636) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Kaplan-Meier survival curves. (A) OS. (B) EFS. (C) Relapse incidence in all patients (solid line) and in patients who underwent BMT with complete remission (CR) of the underlying disease (dashed line). (D) GVHD-EFS. Biology of Blood and Marrow Transplantation 2017 23, 459-466DOI: (10.1016/j.bbmt.2016.12.636) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions